Skip to main content
Equibles

Federation des caisses Desjardins du Quebec

Position in SPRO — Spero Therapeutics, Inc.

CIK 2022297 LEVIS, A8
Back to SPRO Full portfolio

Position in SPRO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$203,099
+$203,069 QoQ
Shares Held
91,900
+306233.3% QoQ
Ownership
0.158%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 59 holders
Holding Since
Mar 2023
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SPRO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Federation des caisses Desjardins du Quebec holds $61,124,856 across 153 Biotechnology names. SPRO ranks #33 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 20,094 $9,981,291
2 ARGX
Argenx SE
 7,637 $7,085,378
3 REGN
Regeneron Pharmaceuticals, Inc.
 10,915 $6,805,937
4 INCY
Incyte Corp
 57,354 $6,501,647
5 RVMD
Revolution Medicines, Inc.
 16,951 $3,174,581
6 MRNA
Moderna, Inc.
 41,572 $2,911,286
7 ALNY
Alnylam Pharmaceuticals, Inc.
 8,591 $2,586,147
8 TECH
BIO-TECHNE Corp
 32,626 $2,305,026

All Filings in SPRO

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $203,099 91,900
2024-12-31 $30 30
2024-09-30 $40 30
2024-06-30 $39 30
2024-03-31 $51 30
2023-12-31 $1,073 730
2023-09-30 $883 730
2023-06-30 $1,058 730
2023-03-31 $1,015 700